Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

LYRA Lyra Therapeutics Inc

0,3635

-0,0085 (-2,28%)

Zuletzt aktualisiert: 19:57:20

Verzögert um 15 Minuten

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Lyra Therapeutics (NASDAQ:LYRA)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Lyra Therapeutics Charts.

Lyra Therapeutics (NASDAQ:LYRA)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Lyra Therapeutics Charts.

News Lyra Therapeutics Inc

Lyra Therapeutics Reports Topline Results from Phase 3 ENLIGHTEN 1 Trial for LYR-210 in Chronic Rhinosinusitis
Montag 6 Mai 2024 (1 Woche vor) • GlobeNewswire Inc.

Lyra Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Dienstag 30 April 2024 (2 Wochen vor) • GlobeNewswire Inc.

Lyra Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Freitag 26 April 2024 (3 Wochen vor) • GlobeNewswire Inc.

Lyra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Donnerstag 21 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Freitag 1 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Donnerstag 15 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Donnerstag 15 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Donnerstag 15 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Dienstag 13 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 1 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Lyra Therapeutics Inc News-Artikel

Dexia Municipal

Lumen Technologies

Euronext S Sanofi 070322...

Vontobel Financial Produ...

Electric & General

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen